Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1919 of 6351
-
Can VR games ease phantom limb pain? new study says maybe
Symptom relief CompletedAfter amputation of an arm or leg, up to 90% of subjects experience a "phantom limb", a phenomenon characterized by persistent feelings of the missing limb. Many subjects with a phantom limb experience intense pain in the missing extremity that is often poorly responsive to medic…
Sponsor: Albert Einstein Healthcare Network • Aim: Symptom relief
Last updated Sep 09, 2026 23:00 UTC
-
Could an 8-Day heart patch prevent your next stroke?
Diagnosis CompletedThe purpose of this study is to evaluate the benefits in the atrial fibrillation detection rate of the continuous ECG monitoring group for more than 8 days by contrasting with one-day ECG monitoring using MEMO Patch PLUS in 1000 patients with atrial fibrillation-related symptoms …
Sponsor: Yonsei University • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
Blood marker may foretell kidney disease severity
Knowledge-focused Recruiting nowICONE study (IgA Complement and NEphropathy is a prospective monocentric observational study. The main objective is to evaluate the relevance of complement activation as a biomarker of disease severity and progression in patients with a biopsy proven IgAN.
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
Can a digital hub keep mentally ill patients healthy at home?
Disease control OngoingIndividuals suffering from Serious Mental Illnesses (SMI) are at risk for serious adverse health and social outcomes compared to the general population due to a high prevalence of chronic physical health disorders such as cardiovascular disease, hypertension, and Type II Diabetes…
Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New shot shows promise for stubborn high fats in blood
Disease control CompletedThe purpose of the study was to evaluate the effect of olezarsen on percent change in fasting triglyceride (TG) levels compared to placebo at Months 6 and 12 and the proportion of participants who achieve different thresholds in fasting TG. Other objectives were to evaluate the e…
Phase 2 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could a light cap ease autism symptoms in young children?
Symptom relief CompletedThe hypothesis of the study is that photobiomodulation reduces symptoms of autism. Participants will be children between the ages of 2 and 7, who have been diagnosed with moderate to severe autism. Transcranial photobiomodulation will be administered to the children in the experi…
Sponsor: JelikaLite LLC • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
Could an asthma drug tame COPD Flare-Ups? new study investigates
Disease control CompletedThe investigators aim to recruit 32 people with COPD who have frequent exacerbations and high eosinophil counts which indicates "asthmatic type" inflammation and treat them for a year with mepolizumab. This is a licenced medication for asthma. Mepolizumab is a monoclonal antibody…
Phase 3 • Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Stroke device could revolutionize heart attack treatment
Disease control CompletedHeart attacks are caused by the sudden formation of a clot inside a diseased coronary artery which reduces blood flow beyond the blockage site. During conventional treatment of the blockage with what is known as a stent; a stainless steel tub that keeps the artery open, the clot …
Sponsor: Oxford University Hospitals NHS Trust • Aim: Disease control
Last updated Jun 26, 2026 13:36 UTC
-
Can community workshops and couple counseling curb HIV in cape town?
Prevention CompletedThis study addresses HIV prevention and treatment for young couples living in Cape Town, South Africa, through a comprehensive biobehavioral multilevel approach-the Couples Health CoOp Plus (CHC+). Through a cluster randomized trial with a modified factorial design, 24 Cape Town…
Sponsor: RTI International • Aim: Prevention
Last updated Jun 27, 2026 07:59 UTC
-
Off-the-Shelf immune cells take on Hard-to-Treat lymphomas
Disease control Recruiting nowThis phase I trial is to find out the best dose, possible benefits and/or side effects of third-party natural killer cells in combination with mogamulizumab in treating patients with cutaneous T-cell lymphoma or adult T-cell leukemia/lymphoma that has come back (relapsed) or does…
Phase 1 • Sponsor: John Reneau • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New drug targets Hard-to-Treat blood cancers in chinese trial
Disease control Recruiting nowThis study aims to explore the recommended phase 2 dose and evaluate the safety, tolerability and preliminary antitumor activity of BGB-16673 monotherapy at the recommended Phase 2 dose for the selected B-cell malignancy expansion cohorts
Phase 1/2 • Sponsor: BeiGene • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Could a Neck-Strengthening device speed up concussion recovery?
Disease control CompletedConcussions occur most frequently in adolescents and often result in significant disruption to daily living for prolonged periods of time. Concussions are an epidemic, with the incidence rates for sports related concussions (SRC) in adolescents up to 0.47 per 1000 athlete exposur…
Sponsor: Western University, Canada • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Could a lung fibrosis drug stop nosebleeds in HHT?
Symptom relief Recruiting nowPatients affected by hereditary hemorrhagic telangiectasia (HHT) very often suffer from recurrent nosebleeds called epistaxis. There is no treatment currently available to reduce the frequency or severity of epistaxis. This research project will examine the effect of nintedanib,…
Phase 2 • Sponsor: Dr. Romain Lazor • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Can drug combo before surgery boost ovarian cancer outcomes?
Disease control Recruiting nowThis is a multi-center, prospective, open-label, phase II trial. Patients with suspected advanced ovarian cancer planned to undergo diagnostic laparoscopy for histologic confirmation and evaluation of disease spread will be registered into the trial after providing a 1st written …
Phase 2 • Sponsor: AGO Research GmbH • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Can a new washing system make fat grafts last longer?
Disease control CompletedProspective, multi-center, non-randomized, open-label, post-market clinical study evaluating adipose graft retention over time from lipoaspirate processed using the AuraGen 1-2-3™ with AuraClens™ Lipoaspirate Wash System.
Sponsor: Tiger Biosciences, LLC. • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Experimental antibody combo shows promise against tough cancers
Disease control Stopped earlyThis is a phase I/IIa, two-part, open-label study to characterize the safety, tolerability, pharmacodynamics, and antitumor activity of ICT01 in combination with LDSC IL-2 in patients with advanced-stage solid tumors. Part 1 will be a dose escalation of IV ICT01 administered on …
Phase 1/2 • Sponsor: ImCheck Therapeutics, an Ipsen company • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Experimental drug combo aims to tame bone marrow cancer
Disease control OngoingThe purpose of the study is to identify the recommended Part 2 dose (R2PD) of imetelstat sodium in combination with ruxolitinib in participants with myelofibrosis (MF) in Part 1, and to evaluate the safety and preliminary clinical activity of the R2PD of imetelstat sodium in comb…
Phase 1 • Sponsor: Geron Corporation • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New drug shows promise for controlling rare immune disorder
Disease control CompletedThis project aims to test the effectiveness of ITACITINIB in sporadic Hemophagocytosis Lymphohistiocytosis (HLHs)
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
MS drug ocrelizumab tested for Long-Term safety in 1,300 patients
Disease control OngoingThis is a Phase IIIb, single-arm, multicenter, OLE study. Participants receiving ocrelizumab as an investigational medicinal product (IMP) in a Roche sponsored Parent study who continue to receive ocrelizumab or are in safety follow-up at the time of the closure of their respecti…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New drug shows promise in shrinking eye cancer before surgery
Disease control CompletedThe purpose of this study is to determine the feasibility and tolerability of neo-adjuvant/adjuvant Darovasertib on uveal melanoma patients. Who is it for? Patients may be eligible to join this study with high-risk uveal melanoma and planned to undergo enucleation Study details…
Phase 2 • Sponsor: St Vincent's Hospital, Sydney • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC